Skip to main content
. Author manuscript; available in PMC: 2019 Nov 13.
Published in final edited form as: AIDS. 2018 Nov 13;32(17):2497–2505. doi: 10.1097/QAD.0000000000001965

Table 4.

Age of first exposure to combination antiretroviral therapy (cART)1 by dental and periodontal outcomes2 among 205 perinatally HIV-infected youth youth ever exposed to cART participating in the Oral Health study in the AMP/PHACS3

< 2 yrs N = 82 2 to 5 yrs N = 85 6+ yrs N = 38 P-value4
DMFS score
- Mean (SD) 5.5 (6.2) 9.5 (11.5) 13.8 (17.2) 0.001
- Median (Q1, Q3) 4 (0; 9) 6 (2; 13) 8.5 (4; 19)

DMFT score
- Mean (SD) 3.9 (4.0) 5.6 (5.0) 7.5 (5.8) < 0.001
- Median (Q1, Q3) 3 (0; 6) 4 (2; 8) 6 (4; 11)

DS
- Mean (SD) 2.3 (3.7) 3.3 (7.8) 4.4 (8.2) 0.27
- Median (Q1, Q3) 1 (0; 3) 1 (0; 3) 1.5 (0; 5)

DT
- Mean (SD) 1.9 (2.7) 2.2 (3.7) 3.0 (4.0) 0.20
- Median (Q1, Q3) 1 (0; 3) 1 (0; 2) 1.5 (0, 5)

Teeth with 2-6 BOP sites
- Mean (SD) 7.4 (7.2) 9.9 (7.0) 11.3 (8.6) 0.01
- Median (Q1, Q3) 5 (2; 11) 8 (4.5; 15) 11.5 (3; 18)
1

cART was defined as any regimen containing at least three drugs from at least two drug classes.

2

DMFS/T: decayed-missing-filled-surface/teeth score; DS: number of decayed surfaces; DT: number of teeth with caries; BOP: bleeding on probing

3

Adolescent Master Protocol (AMP) of the Pediatric HIV/AIDS Cohort Study (PHACS); Note: 4 participants were not exposed to cART

4

Kruskal-Wallis Test